Vertex Pharmaceuticals Inc / Ma

Vertex is a biotechnology company that develops and commercializes drugs for the treatment of cystic fibrosis. Read more

377 Followers on Owler
377 Followers on Owler
377 Followers on Owler
377 Followers on Owler

Vertex Pharmaceuticals Inc / Ma

Vertex is a biotechnology company that develops and commercializes drugs for the treatment of cystic fibrosis. Read more

Reshma Kewalramani's photo - President & CEO of Vertex Pharmaceuticals Inc / Ma

President & CEO

Reshma Kewalramani

CEO Approval Rating

82/100

Founded:

1989

Status:

PublicIndependent CompanyNASDAQVERX

VERTEX PHARMACEUTICALS INC / MA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Ionis is Vertex Pharmaceuticals Inc / Ma's #1 competitor. Ionis's headquarters is in Carlsbad, California, and was founded in 1989. Like Vertex Pharmaceuticals Inc / Ma, Ionis also works within the Biotechnology sector. Ionis generates 188% of Vertex Pharmaceuticals Inc / Ma's revenue.

Amgen is one of Vertex Pharmaceuticals Inc / Ma's top rivals. Amgen was founded in Thousand Oaks, California} in 1980. Amgen operates in the Biotechnology industry. Compared to Vertex Pharmaceuticals Inc / Ma, Amgen generates $24.8B more revenue.

Ironwood is one of Vertex Pharmaceuticals Inc / Ma's top competitors. Ironwood is a Public company that was founded in 1998 in Boston, Massachusetts. Ironwood is in the Pharmaceuticals industry. Compared to Vertex Pharmaceuticals Inc / Ma, Ironwood has 868 fewer employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Merck a competitor of Vertex Pharmaceuticals Inc / Ma?

Vertex Pharmaceuticals Inc / Ma Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$374.7M

Vertex Pharmaceuticals Inc / Ma's revenue is the ranked 16th among it's top 10 competitors. The top 10 competitors average 15.1B. Over the last four quarters, Vertex Pharmaceuticals Inc / Ma's revenue has decreased by 39.6%. Specifically, in Q3 2020's revenue was $94.6M; in Q2 2020, it was $91.3M; in Q3 2019, it was $82.4M; in Q2 2019, Vertex Pharmaceuticals Inc / Ma's revenue was $156.8M.

Vertex Pharmaceuticals Inc / Ma Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Semma Therapeutics, Inc.

Sep 2019

Source »
$950M
Semma Therapeutics is a biotechnology company that develops and commercializes stem cell-based therapies for the treatment of diabetes.
Exonics Therapeutics, Inc.

Jun 2019

Source »
$245M
Exonics is a biotechnology company that focuses on provding gene repair therapies for genetic neuromuscular diseases.

-

INCIVO

Nov 2013

Source »
$152M
-

-

-

Apr 2001

Source »
$592M
-

These are all the companies that Vertex Pharmaceuticals Inc / Ma has acquired. Vertex Pharmaceuticals Inc / Ma has acquired 4 companies and its latest acquisition was Semma Therapeutics, Inc. in Sep 2019. Semma Therapeutics is a biotechnology company that develops and commercializes stem cell-based therapies for the treatment of diabetes.

Vertex Pharmaceuticals Inc / Ma Funding History

Since Vertex Pharmaceuticals Inc / Ma was founded in 1989, it has participated in 1 round of funding. In total Vertex Pharmaceuticals Inc / Ma has raised $443.0M. Vertex Pharmaceuticals Inc / Ma's funding round was on Dec 2009 for a total of $443.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Dec 2009
$443M

Since Vertex Pharmaceuticals Inc / Ma was founded in 1989, it has participated in 1 round of funding. In total Vertex Pharmaceuticals Inc / Ma has raised $443.0M. Vertex Pharmaceuticals Inc / Ma's funding round was on Dec 2009 for a total of $443.0M

Vertex Pharmaceuticals Inc / Ma Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

CPF is a non-profit organization that offers support services for cystic fibrosis patients.
$50K
Dec 03, 2020
Grant
-
Kymera is a biotechnology company that researches, develops and commercializes drug candidates for the treatment of intractable diseases.
$102M
Mar 11, 2020
Series C
Aug 20, 2020
Genomics is a healthcare company that researches and develops therapies for the treatment of genetic diseaeses.
$10.1M
Dec 09, 2018
Series B
-
Genomics is a healthcare company that researches and develops therapies for the treatment of genetic diseaeses.
$32.3M
Aug 29, 2018
Series B
-

These are all the companies that Vertex Pharmaceuticals Inc / Ma has invested in. Vertex Pharmaceuticals Inc / Ma has invested 4 companies and its latest investment was Semma Therapeutics, Inc. in Sep 2019. Semma Therapeutics is a biotechnology company that develops and commercializes stem cell-based therapies for the treatment of diabetes.

Vertex Pharmaceuticals Inc / Ma News

April 27, 2021CompanyNews HQ

Vertex Announces NaV1.8 Inhibitor Advancing to Phase 2 Clinical Development | Vertex Pharmaceuticals

- Proof-of-concept studies of VX-548 in acute pain to initiate in the second half of the year - BOSTO... See more »
April 27, 2021Global Legal Chronicle

CRISPR Therapeutics' Collaboration Agreement with Vertex Pharmaceuticals

Goodwin Procter LLP advised CRISPR Therapeutics on the deal. CRISPR Therapeutics (NASDAQ: CRSP) annou... See more »
April 27, 2021PharmaTimes

EMA PRIME status granted for Vertex, CRISPR Therapeutics' gene therapy CTX001

CRISPR/Cas9 gene-edited therapy is being investigated in transfusion-dependent beta thalassemia... See more »
April 26, 2021BioPharma Dive

Vertex pushes pain drug into mid-stage testing

VX-548 is Vertex's latest attempt to show that blocking a certain sodium channel can offer a new, non... See more »
April 23, 2021PharmaLeaders

Vertex and Obsidian partner to discover gene-editing medicines

Vertex Pharmaceuticals and Obsidian Therapeutics have established a multi-year collaboration for the ... See more »
April 23, 2021The Pharma Letter

Vertex inks licensing deal with Obsidian

In a second collaboration announced by Vertex Pharmaceuticals this week, the US firm says it has ente... See more »

Vertex Pharmaceuticals Inc / Ma Press Releases

December 3, 2020PRWeb

Claire's Place Foundation Receives Grant From Vertex Pharmaceuticals for Work Proudly Program

Program that provides individuals with cystic fibrosis & caregivers tools needed for work-from-home e... See more »
September 24, 2020Business Wire

Vertex prsentiert auf virtuellen Mukoviszidose-Konferenzen in Europa und Nordamerika neue Daten zum Langzeiteinsatz von CFTR-Modulatoren

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) kündigte heute an, dass D... See more »
July 20, 2020Business Wire

Vertex Announces Launch of Initial Public Offering

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Vertex, Inc., a leading provider of tax technology and service... See more »
March 31, 2020PRWeb

Axonius Announces $58 Million in New Funding to Fuel Exponential Growth

Citing Rapid Growth and Customer Acquisition, Cybersecurity Asset Management Leader Plans to Expand P... See more »
September 17, 2019Business Wire

Vertex and Oracle Expand Collaboration to Deliver Tax Automation on Oracle Cloud Infrastructure

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Vertex, Inc., a leading global provider of tax technology and ... See more »
November 13, 2017Accesswire

Vertex's Revenue Soared 40%; Adjusted EPS Rocketed 212%

Research Desk Line-up: Esperion Therapeutics Post Earnings Coverage LONDON, UK / ACCESSWIRE / Novembe... See more »

Vertex Pharmaceuticals Inc / Ma Videos

August 15, 2018Vertex Pharmaceuticals Vimeo Channel

"KALYDECO Expansion 1-2" on VIMEO

Cast: Vertex Pharmaceuticals... See more »
August 9, 2018Vertex Pharmaceuticals Vimeo Channel

"Patient Engagement CF Awareness Month impact" on VIMEO

Cast: Vertex Pharmaceuticals... See more »
February 20, 2018Vertex Vimeo Channel

"Virtual Lab Tour - Mia Tazi" on VIMEO

Cast: Vertex Pharmaceuticals... See more »
August 13, 2015Vertex Pharmaceuticals Vimeo Channel

"2015 interns" on VIMEO

Cast: Vertex Pharmaceuticals... See more »

Social Media

Vertex Pharmaceuticals Inc / Ma Headquarters

50 Northern Avenue

Boston, Massachusetts02210

617-341-6100

Driving Directions »

Trending Companies

Vertex Pharmaceuticals Inc / Ma Summary

ABOUT

Overview

Vertex is a biotechnology company that develops and commercializes drugs for the treatment of cystic fibrosis. Vertex Pharmaceuticals Inc / Ma was founded in 1989. Vertex Pharmaceuticals Inc / Ma's headquarters is located in Boston, Massachusetts, USA...

CEO

Vertex Pharmaceuticals Inc / Ma's President & CEO, Reshma Kewalramani, currently has an approval rating of 82%. Vertex Pharmaceuticals Inc / Ma's primary competitors are Ionis, Amgen & Ironwood.

Website

vrtx.com

Frequently Asked Questions about Vertex Pharmaceuticals Inc / Ma

  1. When was Vertex Pharmaceuticals Inc / Ma founded?

    Vertex Pharmaceuticals Inc / Ma was founded in 1989
  2. Who is Vertex Pharmaceuticals Inc / Ma's CEO?

    Vertex Pharmaceuticals Inc / Ma's CEO is Reshma Kewalramani
  3. How much revenue does Vertex Pharmaceuticals Inc / Ma generate?

    Vertex Pharmaceuticals Inc / Ma generates $374.7M in revenue
  4. How much funding does Vertex Pharmaceuticals Inc / Ma have?

    Vertex Pharmaceuticals Inc / Ma has historically raised $443M in funding
  5. Where is Vertex Pharmaceuticals Inc / Ma's headquarters?

    Vertex Pharmaceuticals Inc / Ma's headquarters is in Boston Massachusetts, USA
  1. How many employees does Vertex Pharmaceuticals Inc / Ma have?

    Vertex Pharmaceuticals Inc / Ma has 1,100 employees
  2. What sector does Vertex Pharmaceuticals Inc / Ma operate in?

    Vertex Pharmaceuticals Inc / Ma is in Biotechnology
  3. Who are Vertex Pharmaceuticals Inc / Ma's competitors?

    Vertex Pharmaceuticals Inc / Ma's top competitors are Ionis, Amgen, Ironwood
  4. Who has Vertex Pharmaceuticals Inc / Ma invested in?

    Vertex Pharmaceuticals Inc / Ma's has invested in companies such as CPF, Kymera, Genomics